FDA Alert - Drug Safety Communication: CardioGen-82 PET Scan - Increased Radiation Exposure

Sent to you from Drugs.com You received this email because you requested to receive drug alerts. Change your notification settings or unsubscribe here.

FDA MedWatch Alert Sent to subscribers of: Cardiogen-82 Drug Safety Communication: CardioGen-82 PET Scan - Increased Radiation Exposure July 15, 2011 Audience: Nuclear Medicine, Radiology, Patients. ISSUE: FDA notified the public and the medical imaging community about the potential for inadvertent, increased radiation exposure in patients who underwent or will be undergoing cardiac positron emission tomography (PET) scans with rubidium (Rb)-82 chloride injection from CardioGen-82 manufactured by Bracco Diagnostics, Inc.   Read more... Get these updates via twitter

Copyright © 2011 Drugs.com. All rights reserved. Change your notification settings or unsubscribe here.